|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/21 | |
| A61K 31/167 | |||
| A61K 31/18 | |||
| A61K 31/395 | |||
| A61P 31/20 |
| (11) | Number of the document | 3102225 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15746664.0 |
| Date of filing the European patent application | 2015-02-05 | |
| (97) | Date of publication of the European application | 2016-12-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/014663 |
| Date | 2015-02-05 |
| (87) | Number | WO 2015/120178 |
| Date | 2015-08-13 |
| (30) | Number | Date | Country code |
| 201461936242 P | 2014-02-05 | US |
| (72) |
HARTMAN, George D., US
|
| (73) |
Novira Therapeutics Inc.,
Welsh & McKean Roads Mailstop SH 22-2-1, Spring House PA 19477,
US
|
| (54) | COMBINATION THERAPY FOR TREATMENT OF HBV INFECTIONS |
| COMBINATION THERAPY FOR TREATMENT OF HBV INFECTIONS |